Serum Institute of India Limited, Pune, India.
Clin Microbiol Infect. 2014 May;20 Suppl 5:37-44. doi: 10.1111/1469-0691.12568. Epub 2014 Mar 7.
Vaccines represent one of the greatest achievements of science and medicine in the fight against infectious diseases. Vaccination is one of the most cost-effective public health tools to prevent infectious diseases. Significant progress has been made in expanding the coverage of vaccines globally, resulting in the prevention of more than two million deaths annually. In 2010, nearly 200 countries endorsed a shared vision to extend the benefits of vaccines to every person by 2020, known as the Decade of Vaccine Initiative (DoV). Vaccine manufacturers in developing countries, as represented by the Developing Countries Vaccine Manufacturers Network (DCVMN), make a significant contribution to DoV by supplying quality vaccines at affordable prices to the people who need them most. About 70% of the global Expanded Program on Immunization (EPI) vaccine supplies are met by DCVMN. Besides EPI vaccine supplies, DCVMN is also targeting vaccines against rotavirus, Japanese encephalitis, pneumonia, human papillomavirus, meningitis and neglected tropical diseases. This article reviews the roles and contributions of DCVMN in making the vaccines accessible and affordable to all.
疫苗是医学和科学在对抗传染病方面取得的最伟大成就之一。接种疫苗是预防传染病最具成本效益的公共卫生手段之一。在扩大疫苗接种范围方面取得了重大进展，每年预防了超过 200 万人死亡。2010 年，近 200 个国家支持了一项共同愿景，即到 2020 年将疫苗的益处扩展到每一个人，这被称为疫苗倡议十年（DoV）。发展中国家疫苗制造商网络（DCVMN）等发展中国家的疫苗制造商通过以负担得起的价格向最需要的人提供高质量的疫苗，为 DoV 做出了重大贡献。大约 70%的扩大免疫规划（EPI）疫苗供应由 DCVMN 满足。除了 EPI 疫苗供应，DCVMN 还针对轮状病毒、日本脑炎、肺炎、人乳头瘤病毒、脑膜炎和被忽视的热带病疫苗。本文回顾了 DCVMN 在使所有人都能获得和负担得起疫苗方面的作用和贡献。
